Sneader W. The discovery of aspirin: A reappraisal. BMJ, 2000;321(7276):1591–4.
Brownstein M.J. A brief history of opiates, opioid peptides, and opioid receptors. Proceed Nat Acad Sci. 1993;90(12):5391–3.
Tu, Y. The discovery of artemisinin (qinghaosu) and gifts from Chinese medicine. Nat Med. 2011;17(10):1217–20.
Li JW, Vederas JC. Drug discovery and natural products: End of an era or an endless frontier? Science. 2009; 325(5937):161–5.
Harvey AL, Edrada-Ebel R, Quinn R.J. The re-emergence of natural products for drug discovery in the genomics era. Nat Rev Drug Disc. 2015;14(2): 111–29.
Newman DJ, Cragg GM. Natural products as sources of new drugs from 1981 to 2014. J Nat Prod.2016;79(3):629–61.
Floss HG, Yu TW. Rifamycin-mode of action, resistance, and biosynthesis. Chem Rev. 2005;105(2):621–32.
Heinrich M, Gibbons S. Ethnopharmacology in drug discovery: An analysis of its role and potential contribution. J Pharm Pharmacol. 2001;53(4):425–32.
Ullah A, Iqbal Z. Digitalization of herbarium data and its potential for ethnobotanical and pharmacological research. J Ethnopharmacol. 2021;268:113689.
Smanski MJ, Zhou H, Claesen J, Shen B, Fischbach MA, Voigt CA. Synthetic biology to access and expand nature’s chemical diversity. Nat Rev Microb, 2016;14(3):135–49.
Choudhury, A., & Rother, D. Access and benefit-sharing of genetic resources and traditional knowledge in India: Implications for bioprospecting. J Intell Prop Rights. 2021;26(2):73–80. 3 Tamboli / Journal of Pharmaceutical and Biological Sciences 2024;13(1):1-3
Hughes JP, Rees S, Kalindjian S.B., Philpott K. L. Principles of early drug discovery. Brit J Pharmacol.2011;162(6):1239–49.
Zumla A, Chan JFW, Azha, EI, Hui DSC., Yuen KY. Coronaviruses — drug discovery and therapeutic options. Nat Rev Drug Dis, 2016;15(5): 327–47.
Atanasov AG., Waltenberger B, Pferschy-Wenzig EM, Linder T, Wawrosch C, Uhrin P, Discovery and resupply of pharmacologically active plant-derived natural products: A review. Biotech Adv. 2015; 33(8):1582–614.
Schroeder D, Orellana MA. Operationalizing the Nagoya Protocol: Challenges and opportunities for genetic resource access and benefit-sharing. Nat Plants, 2019; 5(7):714–5.
×
How to Cite This Article
Vancouver
Tamboli FA. Tracing the path from nature to pharmaceuticals in drug discovery [Internet]. J Pharm Biol Sci. 2025 [cited 2025 Oct 24];13(1):1-3. Available from: https://doi.org/10.18231/j.jpbs.2025.001
APA
Tamboli, F. A. (2025). Tracing the path from nature to pharmaceuticals in drug discovery. J Pharm Biol Sci, 13(1), 1-3. https://doi.org/10.18231/j.jpbs.2025.001
MLA
Tamboli, Firoj A.. "Tracing the path from nature to pharmaceuticals in drug discovery." J Pharm Biol Sci, vol. 13, no. 1, 2025, pp. 1-3. https://doi.org/10.18231/j.jpbs.2025.001
Chicago
Tamboli, F. A.. "Tracing the path from nature to pharmaceuticals in drug discovery." J Pharm Biol Sci 13, no. 1 (2025): 1-3. https://doi.org/10.18231/j.jpbs.2025.001